TherapeuticsMD Inc. (TXMD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    TherapeuticsMD Inc.

    NASDAQ: TXMD · Real-Time Price · USD
    1.07
    -0.01 (-0.93%)
    At close: Sep 05, 2025, 3:57 PM
    1.06
    -0.93%
    After-hours: Sep 05, 2025, 07:06 PM EDT

    TherapeuticsMD Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1.76M 1.3M 69.96M 86.95M
    Cost of Revenue
    		 509K 922K 1.4M 18.84M
    Gross Profit
    		 1.76M 380K 68.57M 68.11M
    Operating Income
    		 -4.76M -8.52M 20.14M -139.77M
    Interest Income
    		 144.9K n/a n/a n/a
    Pretax Income
    		 -2.34M -7.74M 1.07M -172.41M
    Net Income
    		 -2.18M -10.28M 112M -205.6M
    Selling & General & Admin
    		 4.74M 8.9M 57.9M 200.8M
    Research & Development
    		 n/a n/a n/a 7.09M
    Other Expenses
    		 1.78M n/a -117K 272K
    Operating Expenses
    		 6.52M 8.9M 57.9M 207.88M
    Interest Expense
    		 9.5K n/a n/a 32.92M
    Selling & Marketing Expenses
    		 n/a n/a n/a 108.19M
    Cost & Expenses
    		 6.52M 9.82M 59.3M 226.72M
    Income Tax Expense
    		 -31K -43K -91.86M 33.19M
    Shares Outstanding (Basic)
    		 11.53M 10.44M 9.03M 7.96M
    Shares Outstanding (Diluted)
    		 11.53M 10.44M 9.03M 7.96M
    EPS (Basic)
    		 -0.19 -0.55 -10.35 -25.83
    EPS (Diluted)
    		 -0.19 -0.74 -10.35 -25.83
    EBITDA
    		 -2.98M -8.4M 11.86M -78.57M
    EBIT
    		 -3.49M -7.54M 10.66M -79.31M
    Depreciation & Amortization
    		 509K 922K 1.19M 736K

    Add to Watchlist